Latest Stories
JLL (NYSE:JLL) Exceeds Q4 CY2025 Expectations
Real estate firm JLL (NYSE:JLL) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 11.7% year on year to $7.61 billion. Its non-GAAP profit of $8.71 per share was 18.3% above analysts’ consensus estimates.
Verisk (NASDAQ:VRSK) Exceeds Q4 CY2025 Expectations, Stock Soars
Insurance data analytics provider Verisk Analytics (NASDAQ:VRSK) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 5.9% year on year to $778.8 million. On the other hand, the company’s full-year revenue guidance of $3.22 billion at the midpoint came in 1.7% below analysts’ estimates. Its non-GAAP profit of $1.82 per share was 12.9% above analysts’ consensus estimates.
Bausch + Lomb’s (NYSE:BLCO) Q4 CY2025: Beats On Revenue
Eyecare company Bausch + Lomb (NYSE:BLCO) announced better-than-expected revenue in Q4 CY2025, with sales up 9.8% year on year to $1.41 billion. The company’s full-year revenue guidance of $5.43 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $0.32 per share was 10.3% below analysts’ consensus estimates.
Charles River Laboratories (NYSE:CRL) Beats Q4 CY2025 Sales Expectations
Lab services company Charles River Laboratories (NYSE:CRL) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales were flat year on year at $994.2 million. Its non-GAAP profit of $2.39 per share was 1.9% above analysts’ consensus estimates.
Moody's (NYSE:MCO) Surprises With Q4 CY2025 Sales
Credit rating agency Moody's (NYSE:MCO) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 13% year on year to $1.89 billion. Its non-GAAP profit of $3.64 per share was 6.1% above analysts’ consensus estimates.
Analog Devices (NASDAQ:ADI) Posts Better-Than-Expected Sales In Q4, Stock Soars
Manufacturer of analog chips Analog Devices (NASDAQ:ADI) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 30.4% year on year to $3.16 billion. On top of that, next quarter’s revenue guidance ($3.5 billion at the midpoint) was surprisingly good and 8.1% above what analysts were expecting. Its non-GAAP profit of $2.46 per share was 6.6% above analysts’ consensus estimates.
Vita Coco’s (NASDAQ:COCO) Q4 CY2025 Sales Top Estimates
Coconut water company The Vita Coco Company (NASDAQ:COCO) beat Wall Street’s revenue expectations in Q4 CY2025, but sales were flat year on year at $127.8 million. The company’s full-year revenue guidance of $690 million at the midpoint came in 0.9% above analysts’ estimates. Its GAAP profit of $0.09 per share was 29.6% below analysts’ consensus estimates.
Insulet (NASDAQ:PODD) Surprises With Q4 CY2025 Sales
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 31.2% year on year to $783.8 million. The company expects next quarter’s revenue to be around $716.9 million, close to analysts’ estimates. Its non-GAAP profit of $1.55 per share was 6% above analysts’ consensus estimates.
Enpro’s (NYSE:NPO) Q4 CY2025: Strong Sales
Industrial technology solutions provider EnPro Industries (NYSE:NPO) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 14.3% year on year to $295.4 million. Its non-GAAP profit of $1.99 per share was 4% above analysts’ consensus estimates.
Travel + Leisure (NYSE:TNL) Surprises With Q4 CY2025 Sales
Hospitality company Travel + Leisure (NYSE:TNL) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.7% year on year to $1.03 billion. Its non-GAAP profit of $1.83 per share was 0.6% above analysts’ consensus estimates.